Very philosophical, which it pays to be on a day like today. By the way, I have been called many things in my life, but not an "investor relator". I can't decide if that sounds clinical or abberantly sexual.
A secondary was to be expected. The Switch is running out of cash and even if a product is great, what potential customer is going to design it in if that company can't deliver. No one likes dilution, but I don't think they had any other choice. The untapped line of credit wasn't enough to get these new product offerings produced in quantity. At this point, I would say Dr. Ali is "all in".